Cardinal Health, Inc. $CAH Shares Acquired by Private Trust Co. NA

Private Trust Co. NA grew its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 144.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,323 shares of the company’s stock after purchasing an additional 1,373 shares during the quarter. Private Trust Co. NA’s holdings in Cardinal Health were worth $390,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CAH. Greykasell Wealth Strategies Inc. purchased a new position in shares of Cardinal Health during the 1st quarter valued at approximately $26,000. Jones Financial Companies Lllp increased its holdings in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. GW&K Investment Management LLC increased its holdings in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after purchasing an additional 144 shares in the last quarter. Harbor Asset Planning Inc. purchased a new position in shares of Cardinal Health during the 2nd quarter valued at approximately $49,000. Finally, Garde Capital Inc. purchased a new position in shares of Cardinal Health during the 1st quarter valued at approximately $52,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Cardinal Health

In other Cardinal Health news, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider owned 15,431 shares of the company’s stock, valued at $2,298,293.14. The trade was a 64.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jason M. Hollar sold 35,901 shares of Cardinal Health stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the sale, the chief executive officer directly owned 200,000 shares in the company, valued at approximately $30,008,000. This trade represents a 15.22% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 over the last 90 days. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Stock Performance

Cardinal Health stock opened at $156.29 on Monday. The company’s fifty day moving average price is $151.88 and its 200 day moving average price is $151.91. Cardinal Health, Inc. has a 1 year low of $106.98 and a 1 year high of $168.44. The stock has a market capitalization of $37.13 billion, a P/E ratio of 24.23, a P/E/G ratio of 1.32 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. During the same quarter in the previous year, the company posted $1.84 EPS. The firm’s quarterly revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend was Wednesday, October 1st. Cardinal Health’s payout ratio is 31.63%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on CAH shares. UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Wells Fargo & Company reissued an “overweight” rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Finally, Evercore ISI dropped their price target on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 13th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.